This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1993 Feb;20(1):64-9.

Drug resistance modulation in the laboratory and the clinic

W S Dalton¹

Affiliations

PMID: 8475411

Review

Drug resistance modulation in the laboratory and the clinic

W S Dalton. Semin Oncol. 1993 Feb.

. 1993 Feb;20(1):64-9.

Author

W S Dalton¹

Affiliation

¹ University of Arizona Cancer Center, Tucson 85724.

PMID: 8475411

No abstract available

PubMed Disclaimer

Similar articles

[Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
Larsson R, Nygren P, Bergh J. Larsson R, et al. Lakartidningen. 1991 Dec 18;88(51-52):4441-4. Lakartidningen. 1991. PMID: 1774991 Review. Swedish. No abstract available.
[Resistance, the cause of failure in antineoplastic chemotherapies].
Israel L. Israel L. Pathol Biol (Paris). 1989 Feb;37(2):125-7. Pathol Biol (Paris). 1989. PMID: 2652060 French. No abstract available.
Cancer robustness: tumour tactics.
Kitano H. Kitano H. Nature. 2003 Nov 13;426(6963):125. doi: 10.1038/426125a. Nature. 2003. PMID: 14614483 No abstract available.
[Multidrug resistance].
Donenko FV, Sitdikova SM, Moroz LV. Donenko FV, et al. Vopr Onkol. 1991;37(7-8):780-8. Vopr Onkol. 1991. PMID: 1842629 Review. Russian. No abstract available.
Combination chemotherapy--theory and practice.
Capizzi RL, Keiser LW, Sartorelli AC. Capizzi RL, et al. Semin Oncol. 1977 Jun;4(2):227-53. Semin Oncol. 1977. PMID: 327555 Review. No abstract available.

See all similar articles

Cited by

Overcoming drug resistance in ovarian carcinoma.
Fracasso PM. Fracasso PM. Curr Oncol Rep. 2001 Jan;3(1):19-26. doi: 10.1007/s11912-001-0038-z. Curr Oncol Rep. 2001. PMID: 11123865 Review.
Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Kabasakal L, Ozker K, Hayward M, Akansel G, Griffith O, Isitman AT, Hellman R, Collier D. Kabasakal L, et al. Eur J Nucl Med. 1996 May;23(5):568-70. doi: 10.1007/BF00833393. Eur J Nucl Med. 1996. PMID: 8698063
Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival.
Yokoyama H, Ishida T, Sugio K, Inoue T, Sugimachi K. Yokoyama H, et al. Surg Today. 1999;29(11):1141-7. doi: 10.1007/BF02482262. Surg Today. 1999. PMID: 10552331

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database